These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2734093)

  • 1. [Determination of matrix components in the synovial fluid and blood--a novel approach to studying cartilage involvement in joint disease].
    Saxne T
    Nord Med; 1989; 104(6-7):184-6, 188. PubMed ID: 2734093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix proteins: potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis.
    Saxne T; Heinegård D
    J Rheumatol Suppl; 1995 Feb; 43():71-4. PubMed ID: 7752144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macromolecular markers in joint disease.
    Heinegård D; Saxne T
    J Rheumatol Suppl; 1991 Feb; 27():27-9. PubMed ID: 2027121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological markers in osteoarthritis.
    Rousseau JC; Delmas PD
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):346-56. PubMed ID: 17538566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
    Ratcliffe A; Beauvais PJ; Saed-Nejad F
    J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP
    Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases.
    Gomez R; Lago F; Gomez-Reino J; Dieguez C; Gualillo O
    J Mol Endocrinol; 2009 Jul; 43(1):11-8. PubMed ID: 19240195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone. Quantitative assessment of inflammatory and destructive changes in arthritis by MRI.
    Ostergaard M; Stoltenberg M; Gideon P; Sørensen K; Henriksen O; Lorenzen I
    J Rheumatol; 1996 Jul; 23(7):1151-61. PubMed ID: 8823685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological markers of osteoarthritis].
    Thonar EJ; Manicourt DH
    Rev Rhum Ed Fr; 1994 Nov; 61(9 Pt 2):99S-102S. PubMed ID: 7858614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of intermittent fluid pressure of low physiological magnitude on cartilage and inflammation in osteoarthritis. An in vitro study.
    van Valburg AA; van Roy HL; Lafeber FP; Bijlsma JW
    J Rheumatol; 1998 Mar; 25(3):515-20. PubMed ID: 9517773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypothetical biological synovial fluid for treatment of temporomandibular joint disease.
    Meng QG; Long X
    Med Hypotheses; 2008; 70(4):835-7. PubMed ID: 18063487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-induced joint damage in hemophilia.
    Roosendaal G; Lafeber FP
    Semin Thromb Hemost; 2003 Feb; 29(1):37-42. PubMed ID: 12640563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of joint fluid analysis for determining cartilage damage in osteonecrosis of the knee.
    Saito T; Takeuchi R; Mitsuhashi S; Uesugi M; Yoshida T; Koshino T
    Arthritis Rheum; 2002 Jul; 46(7):1813-9. PubMed ID: 12124865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases.
    Garnero P; Rousseau JC; Delmas PD
    Arthritis Rheum; 2000 May; 43(5):953-68. PubMed ID: 10817547
    [No Abstract]   [Full Text] [Related]  

  • 15. Synovial fluid particle analysis in equine joint disease.
    Tew WP
    Mod Vet Pract; 1980 Dec; 61(12):993-7. PubMed ID: 7464782
    [No Abstract]   [Full Text] [Related]  

  • 16. [Damage to cartilage due to pH changes in the joint].
    Schmelzeisen H
    Hefte Unfallheilkd; 1977; (129):235-7. PubMed ID: 21149
    [No Abstract]   [Full Text] [Related]  

  • 17. Keratan sulfate in body fluids in joint disease.
    Thonar EJ; Masuda K; Häuselmann HJ; Uebelhart D; Lenz ME; Manicourt DH
    Acta Orthop Scand Suppl; 1995 Oct; 266():103-6. PubMed ID: 8553836
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
    Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
    Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical and morphological findings in the synovial fluid and their relations to changes in the articular cartilage and capsule].
    Puhl W; Weber M; Kleesiek K; Greiling H
    Hefte Unfallheilkd; 1977; (129):352-3. PubMed ID: 914589
    [No Abstract]   [Full Text] [Related]  

  • 20. Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds.
    Netter P; Kessler M; Burnel D; Hutin MF; Delones S; Benoit J; Gaucher A
    J Rheumatol; 1984 Feb; 11(1):66-70. PubMed ID: 6699835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.